Status:
COMPLETED
Contrast Nephropathy Prevention With N-Acetylcysteine in Acute Myocardial Infarction
Lead Sponsor:
University of Milan
Conditions:
Contrast-Induced Nephropathy
Acute Myocardial Infarction
Eligibility:
All Genders
18-90 years
Phase:
PHASE2
PHASE3
Brief Summary
Patients with acute myocardial infarction undergoing primary angioplasty are at high risk for renal injury due to the toxic effect of contrast agents. Patients developing renal dysfunction after prima...
Eligibility Criteria
Inclusion
- Consecutive patients admitted to the Coronary Care Unit for ST-segment elevation acute myocardial infarction undergoing primary angioplasty. Patients were included if they presented within 12 hours (18 hours for acute myocardial infarction complicated by cardiogenic shock) from the onset of symptoms. -
Exclusion
- Patients in chronic peritoneal or hemodialytic treatment and those with known allergy to N-acetylcysteine.
- \-
Key Trial Info
Start Date :
February 1 2003
Trial Type :
INTERVENTIONAL
End Date :
May 1 2005
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00237614
Start Date
February 1 2003
End Date
May 1 2005
Last Update
July 18 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro Cardiologico Monzino
Milan, Italy, 20138